Literature DB >> 3826129

Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia.

E W Gelfand, C P Rao, J O Minta, T Ham, D B Purkall, S Ruddy.   

Abstract

A nine-year-old white boy with recurrent pneumococcal bacteremia is described. His serum had no hemolytic activity in either the classic or alternative complement pathways. Absence of classic pathway activity was secondary to a homozygous deficiency of C2. The parents had half-normal levels of C2, compatible with an autosomal recessive mode of inheritance. Measurement of serum properdin levels by radial immunodiffusion and enzyme-linked immunoabsorbent assay revealed a profound deficiency in the patient, normal levels in the father, and half-normal levels in the mother, suggesting X-linked inheritance of the deficiency. Addition of purified properdin to the patient's serum fully reconstituted the alternative pathway function. This patient's unique combination of inherited deficiencies of properdin and C2 is a likely explanation for his susceptibility to bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826129     DOI: 10.1016/0002-9343(87)90122-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

2.  Familial properdin deficiency associated with chronic discoid lupus erythematosus.

Authors:  E R Holme; J Veitch; A Johnston; G Hauptmann; B Uring-Lambert; M Seywright; V Docherty; W N Morley; K Whaley
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections.

Authors:  M Schlesinger; Z Nave; Y Levy; P E Slater; Z Fishelson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

4.  IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Authors:  Cheng-Lung Ku; Capucine Picard; Melinda Erdös; Axel Jeurissen; Jacinta Bustamante; Anne Puel; Horst von Bernuth; Orchidée Filipe-Santos; Huey-Hsuan Chang; Tatiana Lawrence; Marc Raes; László Maródi; Xavier Bossuyt; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

5.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

Review 6.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

7.  Inherited complement deficiency in children surviving fulminant meningococcal septic shock.

Authors:  H H Derkx; E J Kuijper; C A Fijen; M Jak; J Dankert; S J van Deventer
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

8.  Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors:  Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

9.  Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families.

Authors:  R Schwertz; E Esser; R A Seger; A Rubinstein; G Hauptmann; V Wahn
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 10.  Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Qian Zhang; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.